The Socioeconomic Cost of Diseases in Korea

질병의 사회.경제적 비용 추계

  • Ko, Suk-Ja (Korea Institute for Health and Social Affairs) ;
  • Jung, Young-Ho (Korea Institute for Health and Social Affairs)
  • Published : 2006.11.30

Abstract

Objectives : The aim of the study was to estimate the annual socioeconomic cost of diseases in Korea. Methods : We estimate both the direct and indirect costs of diseases in Korea during 2003 using a prevalence-based approach. The direct cost estimates included medical expenditures, traffic costs and caregiver's cost, and the indirect costs, representing the loss of production, included lost workdays due to illness and lost earnings due to premature death, which were estimated based on the human capital theory. The cost estimates were reported at three different discount rates (0, 3 and 5%). Results : The cost of diseases in Korea during 2003 was 38.4 trillion won based on 0% discount rate. This estimate represents approximately 5.3% of GDP The direct and indirect costs were estimated to be 22.5 trillion (58.5% of total cost) and 15.9 trillion won (41.5%), respectively. It was also found that the cost for those aged $40\sim49$ accounted for the largest proportion (21.7%) in relation to age groups. The cost of diseases for males was 23.5% higher than that for females. For major diseases, the total socioeconomic costs were 16.0, 13.4, 11.3 and 11.19% for neoplasms, and diseases of the digestive, respiratory and circulatory systems, respectively. Conclusions : This study can be expected to provide valuable information for determining intervention and funding priorities, and for planning health policies.

Keywords

References

  1. Fuchs VR. The contribution of health services to the american economy. Milbank Mem Fund Q 1966; 44(4): 65-103 https://doi.org/10.2307/3349060
  2. Malaney P. Micro-economic Approaches to Evaluation the Burden of Malaria CID Working Paper 2003, No. 99
  3. Colditz GA. Economic costs of obesity. Am J Clin Nutr 1992; 55(suppl 2): 503-507 https://doi.org/10.1093/ajcn/55.2.503s
  4. Wigle DT, Mao Y, Wong T, Lane R. Economic burden of illness in Canada 1986, Chronic Dis Can 1991; 12(suppl 3): 1-37
  5. Moore R, Mao Y, Zhang J, Clarke K. Economic Burden of Illness in Canada. 1993, Ottawa: Canadian Public Health Association, 1997
  6. Health Canada Economic Burden of illness in Canada 1998, Health Canada, Ottawa, 2002
  7. Jung YH, Ko SJ. Estimating socioeconomic costs of five major diseases. Korean Public Finance 2004; 18(2): 77-104 (Korean)
  8. Kim HJ, Park TK, Jee SH, Kang HY, Nam CM. Analysis of socioeconomic costs of smoking in Korea. Korean J Prev Med 2001; 34(3): 183-190 (Korean)
  9. Park TK, Park SB. Study on the economic costs of smoking in Korea. Korean Public Econ 2000; 5(2): 167-195 (Korean)
  10. Jeong BG, Moon OR, Kim NS, Kang JH, Yoon TH, Lee SY, Lee SJ. Socioeconomic costs of obesity for Korean adults. Korean J Prev Med 2002; 35(1): 1-12 (Korean) https://doi.org/10.1006/pmed.2002.1042
  11. No IC, Suh MH, Kim YL. Socioeconomic Costs of Alcohol and Policy Issues, Korea Institute for Health and Social Affairs; 1997 (Korean)
  12. Rice DP, Hodgson TA, Sinsheimer P, Browner W, Kopstein AN. The economic costs of the health effects of smoking, 1984. Milbank Q 1986; 64(4): 489-547 https://doi.org/10.2307/3349924
  13. Kenkel D. Cost of illness Approach, in: Tolley G, Kenkel D, Fabian R, Editor. Valuing Health for Policy: an Economic Approach. Chicago, IL. University of Chicago Press; 1994, p.42-71
  14. National Health Insurance Corporation. 2003 National Health Insurance Statistical Yearbook, 2004 (Korean)
  15. National Health Insurance Corporation. 2003 Medical Aid Statistical Yearbook, 2004 (Korean)
  16. Lee JK. Analysis of out-of-pocket payment in national health insurance, in health insurance forum National Health Insurance Corporation 2002; Fall: 51-72 (Korean)
  17. Korea Institute for Health and Social Affairs. Ministry of Health and Welfare. 2001. National Health and Nutrition Survey, 2002 (Korean)
  18. Koopmanschap MA, van Ineveld BM. Towards a new approach for estimating indirect cost of disease. Soc Sci Med 1992; 34(9): 1005-1010 https://doi.org/10.1016/0277-9536(92)90131-9
  19. Koopmanschap MA, Rutten FF. Indirect costs in economic studies: confronting the confusion. Pharmacoeconomics 1993;4(6):446-454 https://doi.org/10.2165/00019053-199304060-00006
  20. Koopmanschap MA, Rutten FFH, van Ineveld BM, van Roijen L. The friction cost method of measuring the indirect costs of disease. J Health Econ 1995; 14(2): 171-189 https://doi.org/10.1016/0167-6296(94)00044-5
  21. Road Traffic Authority. Estimating and Evaluating Social Costs of Traffic Accident. 2001 (Korean)
  22. Ministry of Labor. Survey Report on Wage Structure. 2004 (Korean)
  23. Smith, D., Gravelle, H. The Practice of Discounting Economic Evaluation of Health Care Interventions. CHE Technical Paper Series 19, 2000
  24. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993; 4(5): 353-365 https://doi.org/10.2165/00019053-199304050-00006
  25. van Roijen L, Essink-Bot ML, Koopmanschap MA, Bonsel G, Rutten FF. Labour and health status in economic evaluation of health care. Int J Technol Assess Health Care 1996; 12(3): 405-415 https://doi.org/10.1017/S0266462300009764